Rapport Therapeutics Statistics
Total Valuation
RAPP has a market cap or net worth of $2.25 billion. The enterprise value is $1.83 billion.
| Market Cap | 2.25B |
| Enterprise Value | 1.83B |
Important Dates
The last earnings date was Wednesday, August 5, 2026, before market open.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
RAPP has 47.98 million shares outstanding. The number of shares has increased by 27.52% in one year.
| Current Share Class | 47.98M |
| Shares Outstanding | 47.98M |
| Shares Change (YoY) | +27.52% |
| Shares Change (QoQ) | +0.50% |
| Owned by Insiders (%) | 4.36% |
| Owned by Institutions (%) | 79.59% |
| Float | 31.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 111.26 |
| Forward PS | n/a |
| PB Ratio | 5.16 |
| P/TBV Ratio | 5.26 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 89.96 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.72, with a Debt / Equity ratio of 0.02.
| Current Ratio | 15.72 |
| Quick Ratio | 15.35 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -39.96% and return on invested capital (ROIC) is -27.09%.
| Return on Equity (ROE) | -39.96% |
| Return on Assets (ROA) | -25.78% |
| Return on Invested Capital (ROIC) | -27.09% |
| Return on Capital Employed (ROCE) | -35.66% |
| Weighted Average Cost of Capital (WACC) | 9.55% |
| Revenue Per Employee | $238,095 |
| Profits Per Employee | -$1.63M |
| Employee Count | 84 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +218.28% in the last 52 weeks. The beta is 0.97, so RAPP's price volatility has been similar to the market average.
| Beta (5Y) | 0.97 |
| 52-Week Price Change | +218.28% |
| 50-Day Moving Average | 39.96 |
| 200-Day Moving Average | 32.66 |
| Relative Strength Index (RSI) | 64.01 |
| Average Volume (20 Days) | 300,265 |
Short Selling Information
The latest short interest is 2.69 million, so 5.61% of the outstanding shares have been sold short.
| Short Interest | 2.69M |
| Short Previous Month | 2.26M |
| Short % of Shares Out | 5.61% |
| Short % of Float | 8.43% |
| Short Ratio (days to cover) | 5.83 |
Income Statement
In the last 12 months, RAPP had revenue of $20.00 million and -$137.16 million in losses. Loss per share was -$3.05.
| Revenue | 20.00M |
| Gross Profit | -21.88M |
| Operating Income | -153.52M |
| Pretax Income | -137.16M |
| Net Income | -137.16M |
| EBITDA | -152.56M |
| EBIT | -153.52M |
| Loss Per Share | -$3.05 |
Balance Sheet
The company has $436.08 million in cash and $10.11 million in debt, with a net cash position of $425.97 million or $8.88 per share.
| Cash & Cash Equivalents | 436.08M |
| Total Debt | 10.11M |
| Net Cash | 425.97M |
| Net Cash Per Share | $8.88 |
| Equity (Book Value) | 422.93M |
| Book Value Per Share | 8.82 |
| Working Capital | 418.43M |
Cash Flow
In the last 12 months, operating cash flow was -$96.68 million and capital expenditures -$467,000, giving a free cash flow of -$97.15 million.
| Operating Cash Flow | -96.68M |
| Capital Expenditures | -467,000 |
| Depreciation & Amortization | 960,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -97.15M |
| FCF Per Share | -$2.02 |
Margins
| Gross Margin | -109.39% |
| Operating Margin | -767.58% |
| Pretax Margin | -685.80% |
| Profit Margin | n/a |
| EBITDA Margin | -762.78% |
| EBIT Margin | -767.58% |
| FCF Margin | n/a |
Dividends & Yields
RAPP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -27.52% |
| Shareholder Yield | -27.52% |
| Earnings Yield | -6.16% |
| FCF Yield | -4.37% |
Analyst Forecast
The average price target for RAPP is $59.30, which is 26.22% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $59.30 |
| Price Target Difference | 26.22% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
RAPP has an Altman Z-Score of 20.27 and a Piotroski F-Score of 1.
| Altman Z-Score | 20.27 |
| Piotroski F-Score | 1 |